AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JAN 8 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Novel rabies virus (RV)-based vaccines can safely protect animals against HIV infection, researchers in the United States report.
RV-based vectors "show great promise as vaccines against other viral diseases such as human immunodeficiency virus type 1 (HIV-1) infection and hepatitis C, but a low residual pathogenicity remains a concern for their use," explained James P. McGettigan and colleagues at Thomas Jefferson University in Philadelphia.
A series of second-generation RV-based vaccines have been rendered apathogenic without sacrificing their antiviral efficacy, McGettigan and coauthors said.
The researchers tested a series of modifications to the SPBN RV vaccine vector, which was designed to express the HIV Gag protein. They replaced an arginine residue with glutamic acid at position 333 in the RV glycoprotein (G) and/or deleted 43 amino acids from RV G's cytoplasmic domain, according to the report.
SPBN-Gag with one or both of these modifications was apathogenic after peripheral or cranial administration in mice, study data showed. The altered vector induced "robust" cellular responses against HIV Gag, comparable in ...
Source: HighBeam Research, Modified rabies virus vectors safe, effective.